相关实验视频

Updated: Jul 5, 2025

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

全基因组CRISPR屏幕,以了解Apicomplexan与宿主相互作用

Eva Hesping^1,2, Justin A Boddey^1,2

¹Infectious Diseases and Immune Defence Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

Molecular microbiology

|January 15, 2024

概括

克里斯普尔/卡斯9技术彻底改变了虫寄生虫的功能基因组学,有助于发现疾病的药物标. 本综述强调了寄生虫与宿主相互作用研究中的关键发现和未来挑战.

科学领域:

寄生虫学的寄生虫学
基因组学就是基因组学.
分子生物学分子生物学

背景情况:

猿复合体寄生虫会导致人类和牲畜的重大疾病.
了解寄生虫生物学对于开发治疗干预措施至关重要.
功能性基因组学是识别药物点的关键.

研究的目的:

审查在Apicomplexa中的CRISPR/Cas9屏幕的关键发现.
讨论CRISPR/Cas9在研究寄生虫与宿主相互作用中的应用.
确定在Apicomplexa中CRISPR/Cas9技术的挑战和未来方向.

主要方法:

使用CRISPR/Cas9进行前置遗传学和全基因组选.
在宿主细胞的Apicomplexan感染期间分析基因功能.
突出了最近CRISPR/Cas9屏幕的发现.

主要成果:

在Apicomplexa中,CRISPR/Cas9屏幕显著提升了功能基因分析.
这项技术使人们能够更深入地了解寄生虫与宿主之间的相互作用.
关键的发现已经确定了潜在的治疗点.

结论:

克里斯普尔/Cas9技术是猿复合体功能基因组学的一个强大的工具.
需要进一步优化才能充分利用CRISPR/Cas9用于寄生虫研究.
持续应用将提高对寄生虫与宿主相互作用和疾病控制的理解.

关键词:

它们是Apicomplexa的复合物.克里斯普尔是什么意思?克里斯普尔是什么意思?这就是Cas9的情况.转向遗传学转向遗传学转向遗传学主机的主机主机的主机主机寄生虫寄生虫是一种寄生虫.

更多相关视频

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Cell Surface Receptor Identification Using Genome-Scale CRISPR/Cas9 Genetic Screens

Published on: June 6, 2020

相关概念视频

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...